Patents by Inventor Diego Tejedor Hernández

Diego Tejedor Hernández has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160010160
    Abstract: A method for prognosing recurrence of prostate cancer (PCa) in a subject following prostatectomy using the outcomes of selected single nucleotide polymorphisms (SNPs) and clinical variables. A method for genotyping PCa associated genetic variations comprising use of a DNA microarray. A microarray for use in the described methods.
    Type: Application
    Filed: July 13, 2015
    Publication date: January 14, 2016
    Applicant: PROGENIKA BIOPHARMA, S.A.
    Inventors: Jokin del Amo, Diego Tejedor Hernandez, Antonio Martinez Martinez, Laureano Simon Buela, Juan Morote Robles
  • Patent number: 9109257
    Abstract: A method for prognosing recurrence of prostate cancer (PCa) in a subject following prostatectomy using the outcomes of selected single nucleotide polymorphisms (SNPs) and clinical variables. A method for genotyping PCa associated genetic variations comprising use of a DNA microarray. A microarray for use in the described methods.
    Type: Grant
    Filed: July 12, 2007
    Date of Patent: August 18, 2015
    Assignee: Progenika Biopharma, S.A.
    Inventors: Jokin Del Amo, Diego Tejedor Hernández, Antonio Martínez Martínez, Laureano Simón Buela, Juan Morote Robles
  • Patent number: 8712696
    Abstract: A method for prognosing a rheumatoid arthritis phenotype using the outcomes of selected single nucleotide polymorphisms (SNPs) and clinical variables. A method for genotyping multiple rheumatoid arthritis associated genetic variations comprising use of a DNA microrarray. A microarray for use in the described methods.
    Type: Grant
    Filed: July 12, 2007
    Date of Patent: April 29, 2014
    Assignee: Progenika Biopharma, S.A.
    Inventors: Arrate Eguiara, Diego Tejedor Hernández, Antonio Martínez Martínez, Laureano Simón Buela
  • Patent number: 8669049
    Abstract: The invention relates to extracorporeal methods of analyzing the presence or absence of mutations which cause familial hypercholesterolemia. The inventive methods describe the way in which said mutations can be detected using a DNA sample from an individual and comprising the following: chain reaction of the polymerase with primers which are complementary to the low-density lipoprotein receptor gene; analysis of the amplified product by sequencing; restriction analysis; single strand conformation polymorphism techniques; heteroduplex analysis and analysis of a device on top of a biochip glass support on which oligonucleotide probes are disposed, which can be used to detect the aforementioned mutations in the DNA.
    Type: Grant
    Filed: January 21, 2004
    Date of Patent: March 11, 2014
    Assignee: Progenika Biopharma, S.A.
    Inventors: Pedro Mata Lopez, Rodrigo Alberto Alonso Karlezi, Pilar Mozas Alonso, Gilberto Reyes Leal, Miguel Pocovi Mieras, Sergio Castillo Fernandez, Diego Tejedor Hernandez, Antonio Martinez Martinez, Miguel Mallen Perez
  • Patent number: 8296073
    Abstract: A method for prognosing osteoporosis phenotypes or estimating osteoporosis quantitative traits comprising determining outcomes for selected SNP variables and clinical variables. Products and methods for genotyping multiple osteoporosis associated genetic variations.
    Type: Grant
    Filed: July 12, 2007
    Date of Patent: October 23, 2012
    Assignees: Progenika Biopharma, S.A., Bioiberica, S.A.
    Inventors: Ainara Cadaval, Diego Tejedor Hernández, Antonio Martínez Martínez, Laureano Simón Buela
  • Patent number: 8153363
    Abstract: An in vitro method for genotyping genetic variations in an individual, and products for use in the method.
    Type: Grant
    Filed: July 7, 2009
    Date of Patent: April 10, 2012
    Assignee: Progenika Biopharma S.A.
    Inventors: Laureano Simón Buela, Antonio Martínez Martínez, Diego Tejedor Hernández, Elisa Jiménez Uribe, Monica López Martínez, Marta Artieda Oseñalde, Lorena Hernández García
  • Patent number: 7914990
    Abstract: An in vitro method for genotyping genetic variations in a individual, and products for use in the method.
    Type: Grant
    Filed: January 12, 2006
    Date of Patent: March 29, 2011
    Assignee: Progenika Biopharma, S.A.
    Inventors: Laureano Simon Buela, Antonio Martinez Martinez, Diego Tejedor Hernandez, Elisa Jimenez Uribe, Monica Lopez Martinez, Marta Artieda Osenalde, Lorena Hernandez Garcia
  • Publication number: 20110045997
    Abstract: The invention relates to an “in vitro” method for determining the global genetic risk a subject has of developing a pathology associated with aging. Said method is based on the combination of particular genetic risks of developing common pathologies associated with aging. Said particular genetic risks are determined from the results obtained from the simultaneous genotyping of certain genetic variations associated with said pathologies associated with aging and the main objective of which is the use thereof in anti-aging medicine.
    Type: Application
    Filed: February 21, 2008
    Publication date: February 24, 2011
    Applicants: PROGENIKA BIOPHARMA, S.A., SABIOBBI, S.L.
    Inventors: Diego Tejedor Hernández, Laureano Simón Buela, Antonio Martínez Martínez, José Ingacio Lao Villadóniga
  • Publication number: 20100185429
    Abstract: A method for prognosing recurrence of prostate cancer (PCa) in a subject following prostatectomy using the outcomes of selected single nucleotide polymorphisms (SNPs) and clinical variables. A method for genotyping PCa associated genetic variations comprising use of a DNA microarray. A microarray for use in the described methods.
    Type: Application
    Filed: July 12, 2007
    Publication date: July 22, 2010
    Inventors: Jokin del Amo, Diego Tejedor Hernandez, Antonio Martínez Martínez, Laureano Simón Buela, Juan Morote Robles
  • Publication number: 20100087441
    Abstract: A method for prognosing a rheumatoid arthritis phenotype using the outcomes of selected single nucleotide polymorphisms (SNPs) and clinical variables. A method for genotyping multiple rheumatoid arthritis associated genetic variations comprising use of a DNA microrarray. A microarray for use in the described methods.
    Type: Application
    Filed: July 12, 2007
    Publication date: April 8, 2010
    Inventors: Arrate Eguiara, Diego Tejedor Hernández, Antonio Martínez Martínez, Laureano Simón Buela
  • Publication number: 20100069334
    Abstract: A method for prognosing osteoporosis phenotypes or estimating osteoporosis quantitative traits comprising determining outcomes for selected SNP variables and clinical variables. Products and methods for genotyping multiple osteoporosis associated genetic variations.
    Type: Application
    Filed: July 12, 2007
    Publication date: March 18, 2010
    Inventors: Ainara Cadaval, Diego Tejedor Hernández, Antonio Martínez Martínez, Laureano Simón Buela
  • Publication number: 20100068710
    Abstract: An in vitro method for genotyping genetic variations in an individual, and products for use in the method.
    Type: Application
    Filed: July 7, 2009
    Publication date: March 18, 2010
    Applicant: Progenika BioPharma S.A.
    Inventors: Laureano Simón Buela, Antonio Martinez Martinez, Diego Tejedor Hernández, Elisa Jiménez Uribe, Monica López Martinez, Marta Artieda Oseñalde, Lorena Hernández Garcia